Vir Biotechnology, Inc. (VIR) stock forecast and price target
Price $9.96 · data as of November 13, 2026
12-month price target
Average target$23.38
Upside / downside+134.7%
Analysts8
ConsensusStrong buy
Low $17.00Average $23.38High $30.00
Gold marker: average target · white marker: today’s price ($9.96)
Analyst ratings
Strong buy 3Buy 5Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.99 | +68.5% | $330M |
| Next fiscal year ends December 31, 2027 | $-2.39 | −140.5% | $67M |
| Next quarter ends December 31, 2026 | $-0.06 | +79.7% | $87M |
| Quarter after ends March 31, 2027 | $-0.44 | +48.0% | $17M |
Consensus of the analysts covering Vir Biotechnology, updated daily. In the last 30 days 2 estimates were raised and 0 lowered.
Frequently asked questions
What is the Vir Biotechnology stock price target?
The average 12-month target from 8 analysts is $23.38, 134.7% above the current price of $9.96 Targets range from $17.00 to $30.00.
Is Vir Biotechnology a buy according to analysts?
The consensus rating is “Strong buy” (3 strong buy, 5 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Vir Biotechnology expected to earn?
Analysts expect EPS of $-0.99 for the fiscal year ending December 31, 2026 and $-2.39 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.